Ms Kiran Mazumdar, Chairman, Biocon, India will be speaking on the above topic at Pharma Partnering & Investment World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Ms Mazumdar’s pioneering efforts in biotechnology have drawn global recognition both for Indian Industry and Biocon. Her unique vision has steered Biocon’s transition from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Biocon is today recognised as India’s pioneering biotech enterprise. As Chairperson and Mission Leader of CII’s National Task Force on Biotechnology she has led several delegations to USA, Canada, UK, etc. to propel India into the global super league of biotech trailblazers. She chairs Karnataka’s Vision Group on Biotechnology and has served on the Board of Science Foundation, Ireland. She also serves on the Advisory Council of the Government's Department of Biotechnology where she has been instrumental in bringing government, industry and academia together, to chart a clear and progressive growth path for Biotechnology in India.
Ms Mazumdar is the recipient of several prestigious awards including the ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Young’s Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Her most cherished awards however are two of India's highest civilian honours – the PADMASHRI (1989) presented to her by the erstwhile President of India, for her pioneering efforts in Industrial Biotechnology and the PADMABHUSHAN (2005) received from the President of India, Dr. APJ Abdul Kalam. A successful technocrat of global standing, Ms Mazumdar is highly respected in the corporate world. She is a much sought after biotech pioneer who has been referred to as “India’s Biotech Queen” by The Economist and “India’s mother of invention” by New York Times.
She will be presenting on the following:
Alliance models that are enabling Asian and Global pharmas to deliver sustainable, syngergistic growth
1. Understanding synergies between Asian biotechs for successful commercialization of technology with global pharmas
2. Identifying innovative research collaborations in Asia for a win-win partnership between global pharmas and Asian biotechs
3. Overcoming the challenges faced by Asian biotechs when collaborating with global pharmas